Amadix
Founded 2010 · 46 employees on LinkedIn · 3 known investors
Find your way into Amadix
139 people in our graph can introduce you to the Amadix team.
Sign up to see every warm intro you have to Amadix
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Amadix team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Amadix develops blood-based diagnostic tests for early cancer detection before symptoms appear. The company focuses on non-invasive liquid biopsy technology to identify tumors years earlier than traditional methods.
Founders & leadership
Amadix was founded in 2010 by Rocio Arroyo.
RA

Rocio ArroyoFounder · CEORocio Arroyo is CEO and founder of Amadix, which develops multimodal algorithms and liquid biopsy technology for early cancer detection. She serves on the boards of several Spanish research and innovation organizations, including the National Research Council (CSIC) and the Spanish Bioindustry Association (AseBio).
Investors · 3
Capital Celllisted by Capital CellBarcelona
How we know: Capital Cell's portfolio page · funding news · amadix.com · Not right? Tell us
CRB InverbíoreportedMadrid
How we know: funding news · Not right? Tell us
In the news
Frequently asked questions
- What does Amadix do?
- Amadix develops blood-based diagnostic tests for early cancer detection before symptoms appear. The company focuses on non-invasive liquid biopsy technology to identify tumors years earlier than traditional methods.
- Who founded Amadix?
- Amadix was founded by Rocio Arroyo in 2010.
- Who are Amadix's investors?
- Amadix's investors include Capital Cell, Dozen Investments, CRB Inverbío.


